Ipamorelin + CJC-1295 No DAC Blend (20MG) Pharmatide Global product presentationGrowth & Muscle Research
Growth & Muscle Research · USA customer & distributor supply

Ipamorelin + CJC-1295 No DAC Blend (20MG)

Combined growth-axis pathway research. Product information for direct research customers, laboratories, purchasing teams and distributors. Specification, current-batch documents, packaging, MOQ and lead time are confirmed by quotation.

Product Identity & Research Format

ProductIpamorelin + CJC-1295 No DAC Blend (20MG)
Research focusCombined growth-axis pathway research
Available formLyophilised research blend
CAS number170851-70-4 / 863288-34-0
Supply channelsDirect research customers, laboratories, procurement teams and distributors
Intended supplyResearch, laboratory and manufacturing use only
User-provided third-party reports

COA & Batch Documents

1 report

Analytical Documentation

Available analytical capabilities listed by Pharmatide Global are NMR, RP-HPLC, LC-MS, Bioburden Testing, Endotoxin (LPS) Testing. Exact methods, specifications and current batch documents are confirmed in the quotation.

USA Packaging & Shipment Planning

Direct customers and distributors should provide quantity, packaging, consignee, broker details and destination ZIP code. Carrier, tracking, documents and estimated transit are confirmed by quotation. Review USA shipment planning.